Skip to content
Fencer Intel
critical 9.9

CVE-2026-72868 json

Dokploy: Member-role RCE as host root via destination.testConnection rclone shell injection

published 3mo ago modified 2d ago also EUVD-2026-55726

cvss
9.9
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.7%
EPSS 0.7% chance of exploitation in 30 days, percentile 53%
public exploits
0
none known

Summary

Dokploy is a free, self-hostable Platform as a Service (PaaS). Prior to 0.29.13, apps/dokploy/server/api/routers/destination.ts interpolates the accessKey, secretAccessKey, region, endpoint, provider, and bucket fields from destination.testConnection into an rclone ls command executed through child_process.exec. The `withPermission("destination", "create")` path permits a low-privileged organization member to reach the mutation, close a quoted argument with a crafted field, and execute arbitrary commands in the root Dokploy container, which has access to the host Docker socket. This issue is fixed in version 0.29.13.

Patch / fix

Is CVE-2026-72868 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
none
Automatable
no
Technical impact
total
Assessed
2mo ago

Exploit prediction

0.71% chance of exploitation in the next 30 days, higher than 53% of all scored CVEs (FIRST EPSS, 2026-11-11).

CVSS scores

assigned by version score vector
CNA 3.1 9.9 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Affected products

  • Dokploy dokploy

Classification

Weakness
  • CWE-78 Improper Neutralization of Special Elements used in an OS Command
  • CWE-862 Missing Authorization

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.